Everolimus
Author:
- Vladimir BeljanskiVBVladimir Beljanski
- 1 January 2008
- book chapter
- Published by Elsevier
- p. 1-5
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignanciesCurrent Treatment Options in Oncology, 2006
- Clinical Pharmacokinetics of EverolimusClinical Pharmacokinetics, 2004
- Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RADBritish Journal of Clinical Pharmacology, 2000
- Tissue Distribution and Clinical Monitoring of the Novel Macrolide Immunosuppressant SDZ-RAD and Its Metabolites in Monkey Lung Transplant Recipients: Interaction with CyclosporineThe Journal of Pharmacology and Experimental Therapeutics, 2000
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997